• This record comes from PubMed

Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial

. 2018 Nov ; 33 (11) : 1282-1287. [epub] 20180518

Language English Country Japan Media print-electronic

Document type Journal Article, Multicenter Study, Randomized Controlled Trial

Links

PubMed 29777297
DOI 10.1007/s00380-018-1184-7
PII: 10.1007/s00380-018-1184-7
Knihovny.cz E-resources

This study assessed the Optical Coherence Tomography (OCT) impact on the coronary flow in ST-elevation myocardial infarction (STEMI) after bioresorbable scaffold implantation. Only few data about OCT use in STEMI are available and coronary flow before and after OCT is not well studied yet. 54 patients with OCT performed at the end of procedure from the Prague 19 trial were selected and coronary flow was evaluated as TIMI frame count (TFC) before and just after OCT. Significant increase in TIMI frame count after OCT [from 9.5 (6.75-12.25) to 11.5 (8-15.25) frames; p = 0.001] and high verapamil administration (18%) was reported. OCT at the end of primary percutaneous coronary intervention with bioresorbable scaffold is a feasible procedure. However, it seems to be associated with flow deterioration.

See more in PubMed

Circulation. 2016 Sep 27;134(13):906-17 PubMed

Science. 1991 Nov 22;254(5035):1178-81 PubMed

Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):96-107 PubMed

Am J Cardiol. 2008 Mar 1;101(5):562-7 PubMed

Lancet. 2016 Nov 26;388(10060):2618-2628 PubMed

EuroIntervention. 2009 May;5(1):90-5 PubMed

EuroIntervention. 2010 Nov;6(5):575-81 PubMed

Circulation. 1996 Mar 1;93(5):879-88 PubMed

Eur Heart J. 2010 Feb;31(4):401-15 PubMed

Eur Heart J. 2014 Mar;35(12):787-94 PubMed

Lancet. 2008 Mar 15;371(9616):899-907 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...